CRGX
Price
$4.08
Change
-$0.10 (-2.39%)
Updated
Mar 31, 04:59 PM (EDT)
Capitalization
192.5M
Earnings call today
IKT
Price
$2.19
Change
-$0.10 (-4.37%)
Updated
Mar 31, 04:59 PM (EDT)
Capitalization
166.44M
Ad is loading...

CRGX vs IKT

Header iconCRGX vs IKT Comparison
Open Charts CRGX vs IKTBanner chart's image
CARGO Therapeutics
Price$4.08
Change-$0.10 (-2.39%)
Volume$10.41K
Capitalization192.5M
Inhibikase Therapeutics
Price$2.19
Change-$0.10 (-4.37%)
Volume$1.2K
Capitalization166.44M
CRGX vs IKT Comparison Chart
Loading...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRGX vs. IKT commentary
Mar 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRGX is a Hold and IKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 31, 2025
Stock price -- (CRGX: $4.18 vs. IKT: $2.29)
Brand notoriety: CRGX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRGX: 20% vs. IKT: 58%
Market capitalization -- CRGX: $192.5M vs. IKT: $166.44M
CRGX [@Biotechnology] is valued at $192.5M. IKT’s [@Biotechnology] market capitalization is $166.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRGX’s FA Score shows that 1 FA rating(s) are green whileIKT’s FA Score has 0 green FA rating(s).

  • CRGX’s FA Score: 1 green, 4 red.
  • IKT’s FA Score: 0 green, 5 red.
According to our system of comparison, CRGX is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRGX’s TA Score shows that 3 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • CRGX’s TA Score: 3 bullish, 4 bearish.
  • IKT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IKT is a better buy in the short-term than CRGX.

Price Growth

CRGX (@Biotechnology) experienced а 0.00% price change this week, while IKT (@Biotechnology) price change was -3.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.99%. For the same industry, the average monthly price growth was -10.65%, and the average quarterly price growth was -10.06%.

Reported Earning Dates

CRGX is expected to report earnings on May 14, 2025.

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (-8.99% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRGX($192M) has a higher market cap than IKT($166M). IKT YTD gains are higher at: -29.538 vs. CRGX (-71.012). IKT has higher annual earnings (EBITDA): -20.04M vs. CRGX (-160.43M). CRGX has more cash in the bank: 340M vs. IKT (3.24M). IKT has less debt than CRGX: IKT (145K) vs CRGX (29.4M). CRGX (0) and IKT (0) have equivalent revenues.
CRGXIKTCRGX / IKT
Capitalization192M166M116%
EBITDA-160.43M-20.04M801%
Gain YTD-71.012-29.538240%
P/E RatioN/AN/A-
Revenue00-
Total Cash340M3.24M10,481%
Total Debt29.4M145K20,276%
TECHNICAL ANALYSIS
Technical Analysis
CRGXIKT
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
78%
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 13 days ago
84%
Declines
ODDS (%)
Bearish Trend 6 days ago
79%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Ad is loading...
CRGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCAYX10.80-0.16
-1.46%
Invesco Income Advantage U.S. Fund Y
OAKLX78.67-1.66
-2.07%
Oakmark Select Investor
GTSAX26.12-0.58
-2.17%
Invesco Small Cap Growth A
AMOMX20.28-0.47
-2.27%
AQR Large Cap Momentum Style I
PLAEX27.44-0.69
-2.45%
Plumb Equity A

CRGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRGX has been loosely correlated with ALLO. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if CRGX jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRGX
1D Price
Change %
CRGX100%
+0.24%
ALLO - CRGX
41%
Loosely correlated
-0.64%
IKT - CRGX
39%
Loosely correlated
-3.38%
CRNX - CRGX
39%
Loosely correlated
-0.49%
PRME - CRGX
38%
Loosely correlated
+2.05%
CELC - CRGX
37%
Loosely correlated
-2.85%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
-3.38%
CRGX - IKT
39%
Loosely correlated
+0.24%
VERV - IKT
33%
Poorly correlated
-1.14%
RNTX - IKT
25%
Poorly correlated
-3.95%
KRYS - IKT
25%
Poorly correlated
+0.64%
CYTK - IKT
25%
Poorly correlated
+0.47%
More